{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 5874"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or\n\t\t\t trade of prescription drugs knowingly caused to be adulterated or\n\t\t\t misbranded, to establish recall authority regarding drugs, and for other\n\t\t\t purposes."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20141211", "#text": "December 11, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "sponsor": {"#tail": " introduced the following bill; which was referred to the ", "#text": "Mr. Israel", "@name-id": "I000057"}, "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H16AA1D67A133415B8A0C1E44AC29E0B1", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "#text": "This Act may be cited as ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n      ", "quote": [{"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "Tim Fagan\u2019s Law", "@value": "Tim Fagan\u2019s Law", "@proposed": "true"}, "#text": "\n              "}, "#tail": " or the ", "#text": "\n          "}, {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "Counterfeit Drug Enforcement Act of 2014", "@value": "Counterfeit Drug Enforcement Act of 2014", "@proposed": "true"}, "#text": "\n              "}, "#tail": ".", "#text": "\n          "}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "@display-inline": "no-display-inline", "#text": "\n      ", "@id": "HB3C9A44DA3A34EB7A090E47447014DFF"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Sale or trade of prescription drugs knowingly caused to be adulterated or misbranded;\n\t\t\t misrepresentation as approved drugs"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following paragraphs:", "{http://namespaces.cato.org/catoxml}entity-ref": {"act-name": {"#tail": " (", "@parsable-cite": "FFDCA", "#text": "\n            Federal Food, Drug, and Cosmetic Act\n          "}, "#tail": "\n            ", "@entity-type": "act", "#text": "Section 303(a) of the ", "@value": "Federal Food, Drug, and Cosmetic Act/s:303/ss:a"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 333(a)", "@value": "usc/21/333/a"}, "@parsable-cite": "usc/21/333", "#text": "\n            ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Criminal penalty"}, "quoted-block": {"@act-name": "Federal Food, Drug, and Cosmetic Act", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "paragraph": [{"@indent": "up1", "#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:a"}, {"#tail": ", or\n\t\t\t ", "@entity-type": "act", "#text": "(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:b"}, {"#tail": " with respect to a drug that is subject to ", "@entity-type": "act", "#text": "(c) of section 301", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:c"}, {"#tail": ", if the person knowingly caused the drug to be adulterated or\n\t\t\t misbranded and sells or trades the drug, or the person purchases or trades\n\t\t\t for the drug knowing or having reason to know that the drug was knowingly\n\t\t\t caused to be adulterated or misbranded, the person shall be fined in\n\t\t\t accordance with title 18, United States Code, or imprisoned for any term\n\t\t\t of years or for life, or both.", "@entity-type": "act", "#text": "section\n\t\t\t 503(b)(1)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1/sp:B"}], "#text": "Notwithstanding paragraph (1) or (2), in the case of a person who violates "}, "enum": {"#tail": "\n            ", "#text": "(3)"}, "#text": "\n            ", "@id": "HF87FC1DD690F4FC3B1FEA212CCE304BA"}, {"@indent": "up1", "#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " with\n\t\t\t respect to a drug, if the person caused the drug to be misrepresented as a\n\t\t\t drug that is subject to ", "@entity-type": "act", "#text": "section 301(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:d"}, {"#tail": " and for which an approved\n\t\t\t application is in effect under ", "@entity-type": "act", "#text": "section 503(b)(1)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1/sp:B"}, {"#tail": " and the person sells or trades\n\t\t\t the drug, or the person purchases or trades for the drug knowing or having\n\t\t\t reason to know that the drug was knowingly caused to be so misrepresented,\n\t\t\t the person shall be fined in accordance with ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ",\n\t\t\t or imprisoned for any term of years or for life, or both.", "@entity-type": "uscode", "#text": "title 18, United States Code", "@value": "usc/18"}], "#text": "Notwithstanding paragraph (1) or (2), in the case of a person who violates ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(4)"}, "#text": "\n            ", "@id": "HF6F26254B27848F7AD4840E3C5968CDE"}], "#text": "\n\t\t\t\t\t", "@id": "HE4CE3FDBF09F4D32AB0F7B617726937E"}, "#text": "\n        ", "@id": "HD856D623796B48AB9BC894A45926B874"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following paragraph:", "{http://namespaces.cato.org/catoxml}entity-ref": {"act-name": {"#tail": " (", "@parsable-cite": "FFDCA", "#text": "\n            Federal Food, Drug, and Cosmetic Act\n          "}, "#tail": "\n            ", "@entity-type": "act", "#text": "Section 505(k) of the ", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:k"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(k)", "@value": "usc/21/355/k"}, "@parsable-cite": "usc/21/355", "#text": "\n            ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Notification of Food and Drug Administration by manufacturers"}, "quoted-block": {"@act-name": "Federal Food, Drug, and Cosmetic Act", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "paragraph": {"@indent": "up1", "#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:303/ss:a/p:3", "@proposed": "true"}, {"#tail": " may have occurred with respect to the drug shall report such\n\t\t\t information to the ", "@entity-type": "act", "#text": "(4) of section\n\t\t\t 303(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:303/ss:a/p:4", "@proposed": "true"}, {"#tail": " not later than 48 hours after first receiving\n\t\t\t or otherwise becoming aware of the information.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "A manufacturer of a drug that receives or otherwise becomes aware of information that reasonably\n\t\t\t suggests that a violation described in "}, "enum": {"#tail": "\n            ", "#text": "(6)"}, "#text": "\n            ", "@id": "HB368FF23A3564755967671E829115BFC"}, "#text": "\n\t\t\t\t\t", "@id": "H5B8D1DF858124C3ABE498472C2A23B03"}, "#text": "\n        ", "@id": "HC692BBB099AC4E5E856C208179B26525"}], "#text": "\n      ", "@id": "H5F82764526E24CE48EE138DAA2810538"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 502 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:502"}, "#text": "\n        ", "external-xref": {"#tail": ") is amended by adding at the\n\t\t\t end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 352", "@value": "usc/21/352"}, "@parsable-cite": "usc/21/352", "#text": "\n          ", "@legal-doc": "usc"}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Use of technologies for preventing counterfeiting of drugs"}, "quoted-block": {"@style": "traditional", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "item": {"@indent": "up5", "#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t requiring the use of technologies that the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " has determined are\n\t\t\t technically feasible and will assist in preventing violations of this Act\n\t\t\t to which ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "paragraphs (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:303/ss:a/p:3", "@proposed": "true"}, {"#tail": " apply (relating to the\n\t\t\t knowing adulteration or misbranding of drugs and the knowing\n\t\t\t misrepresentation of drugs).", "@entity-type": "act", "#text": "(4) of section 303(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:303/ss:a/p:4", "@proposed": "true"}], "#text": "If it is a drug and it is not manufactured in accordance with any regulations of the "}, "enum": {"#tail": "\n          ", "#text": "(dd)"}, "#text": "\n          ", "@id": "HA195FA9AB5B345A398668EF77B92454E"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "H4A7FDEA131554BBFB255135B68B7E297"}, "#text": "\n      ", "@id": "H740C545B222540319EC392409CA1DF55"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ", in addition to other authorizations of\n\t\t\t appropriations that are available for such purpose.", "#text": "$60,000,000 for each of the fiscal\n\t\t\t years 2015 through 2018", "@amount": "60000000", "@year": "2015, 2016, 2017, 2018"}, "@entity-type": "auth-auth-approp", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}property": {"act-name": {"#tail": " with respect to violations described in ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, "@parsable-cite": "FFDCA", "#text": "\n          "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to conduct\n\t\t\t inspections, examinations, and investigations under the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " and ", "@entity-type": "act", "#text": "paragraphs (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:303/ss:a/p:3", "@proposed": "true"}, {"#tail": "\n          ", "@entity-type": "act", "#text": "(4) of section 303(a) of such Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:303/ss:a/p:4", "@proposed": "true"}], "#tail": ",\n\t\t\t there is authorized to be appropriated ", "@name": "purpose", "#text": "For the purpose of increasing the capacity of the "}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Counterfeit drugs; increased funding for inspections, examinations, and investigations"}, "#text": "\n      ", "@id": "H772F7984B2B049EF8F51388EB36B3D12"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n\t\t\t", "#text": "Public education regarding counterfeit drugs"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall carry out a program to educate the public and\n\t\t\t health care professionals on counterfeit drugs, including techniques to\n\t\t\t identify drugs as counterfeit.", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "#text": "\n        ", "@id": "HC88579C6DF53472BA1A5BF7707B6177C"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ", in addition to other\n\t\t\t authorizations of appropriations that are available for such purpose.", "#text": "$5,000,000\n\t\t\t for each of the fiscal years 2015 through 2018", "@amount": "5000000", "@year": "2015, 2016, 2017, 2018"}, "@entity-type": "auth-auth-approp", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}property": {"#tail": ", there is authorized to be appropriated ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Counterfeit Drug Enforcement Act of 2014/s:5/ss:a", "@proposed": "true"}, "#text": "For the purpose of carrying out ", "@name": "purpose"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Authorization of appropriations"}, "#text": "\n        ", "@id": "HA970F90F57B949C0805FAD8064555357"}], "#text": "\n      ", "@id": "H8DEC5B8E31EC49528174123EE6A2E530"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " the following section:", "@entity-type": "act", "#text": "section 506F", "@value": "Federal Food, Drug, and Cosmetic Act/s:506F"}, "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by inserting after ", "{http://namespaces.cato.org/catoxml}entity-ref": {"act-name": {"#tail": " (", "@parsable-cite": "FFDCA", "#text": "\n          Federal Food, Drug, and Cosmetic Act\n        "}, "#tail": "\n          ", "@entity-type": "act", "#text": "Subchapter A of chapter V of the ", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V/sch:A"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 351 et seq.", "@value": "usc/21/351/etseq"}, "@parsable-cite": "usc/21/351", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "6."}, "header": {"#tail": "\n      ", "#text": "Recall authority regarding drugs"}, "quoted-block": {"@act-name": "Federal Food, Drug, and Cosmetic Act", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "506G."}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Recall authority"}, "subsection": [{"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Order To cease distribution of drug; notification of health professionals"}, "paragraph": [{"#tail": "\n            ", "@id": "HA4A599C184224C9D8E749AD4FA158A1E", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " finds that a drug intended for human use may constitute a threat to the public\n\t\t\t health, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall issue an order requiring the appropriate\n\t\t\t person (including the manufacturers, importers, distributors, or retailers\n\t\t\t of the drug)\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If the ", "@display-inline": "yes-display-inline"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "to immediately cease distribution of the drug; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H62804DB10717459EA4992A6738923FF8", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "to immediately notify health professionals of the order and to instruct such professionals to cease\n\t\t\t administering, distributing, selling, or prescribing the drug."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H567E6881BFE94AFF9F302533630CF799", "#text": "\n                "}]}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " determines that inadequate grounds exist to support the actions\n\t\t\t required by the order, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall vacate the order.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "An order under paragraph (1) shall provide the person subject to the order with an opportunity for\n\t\t\t an informal hearing, to be held not later than 10 days after the date of\n\t\t\t the issuance of the order, on the actions required by the order and on\n\t\t\t whether the order should be amended to require a recall of the drug\n\t\t\t involved. If, after providing an opportunity for such a hearing, the\n\t\t\t "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Informal hearing"}, "#text": "\n              ", "@id": "HFE9C81F6C445427B903B9CE0C6CBD623"}], "#text": "\n            ", "@id": "H0450C03C68974ECEAFA643383BCC8C80"}, {"#tail": "\n        ", "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Order To recall drug"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t determines that the order should be amended to include a recall of the\n\t\t\t drug with respect to which the order was issued, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall,\n\t\t\t except as provided in paragraphs (2) and (3), amend the order to require a\n\t\t\t recall. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall specify a timetable in which the drug recall\n\t\t\t will occur and shall require periodic reports to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " describing\n\t\t\t the progress of the recall.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If, after providing an opportunity for an informal hearing under subsection (a)(2), the "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "#text": "\n              ", "@id": "H51204AD1000B4BE2A2CCBC473CE17E58"}, {"#tail": "\n            ", "@id": "H68A2A390ECEF495F8BC7C95F8A182536", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Certain actions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "An amended order under paragraph (1)\u2014"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "shall not require recall of a drug from individuals; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H60FEB005EF714B6581E72CBDB15C2CE1", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "shall provide for notice to individuals subject to the risks associated with the use of the drug."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H4E0455AC4ADA4B71A9E82C95DB698622", "#text": "\n                "}]}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may use the assistance of\n\t\t\t health professionals who administered the drug involved to individuals or\n\t\t\t prescribed the drug for individuals. If a significant number of such\n\t\t\t individuals cannot be identified, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall notify such\n\t\t\t individuals pursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "section 705(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:705/ss:b"}], "#text": "In providing the notice required by paragraph (2)(B), the "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Assistance of health professionals"}, "#text": "\n              ", "@id": "H7655D56377BB450389303352A0EAF5F9"}], "#text": "\n            ", "@id": "HFE0992F2D11048F7B1CB8C8C991371BB"}], "#text": "\n          ", "@id": "H2488921EF3944B1388C96A98BC61EE21"}, "#text": "\n\t\t\t\t", "@id": "H38519CA450A94CC6B6DDA03BFD7A0483"}, "#text": "\n      ", "@id": "HC60267D6F3AA4BCA8A53D5B3D7ABF8E8"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following subsection:", "{http://namespaces.cato.org/catoxml}entity-ref": {"act-name": {"#tail": " (", "@parsable-cite": "FFDCA", "#text": "\n          Federal Food, Drug, and Cosmetic Act\n        "}, "#tail": "\n          ", "@entity-type": "act", "#text": "Section 303 of the ", "@value": "Federal Food, Drug, and Cosmetic Act/s:303"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 333(a)", "@value": "usc/21/333/a"}, "@parsable-cite": "usc/21/333", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "7."}, "header": {"#tail": "\n      ", "#text": "Authority to issue subpoenas with respect to preventing threats to the public health"}, "quoted-block": {"@style": "traditional", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "subsection": {"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall develop and implement a procedure through which the\n\t\t\t Chief Counsel in the ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": " is authorized to issue\n\t\t\t subpoenas regarding investigations under this Act of acts or omissions\n\t\t\t that may constitute a threat to the public health, including\n\t\t\t investigations of alleged violations to which paragraph (3) or (4) of\n\t\t\t subsection (a) apply and alleged violations with respect to which the\n\t\t\t Secretary is considering the use of authorities under ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": ".", "@entity-type": "act", "#text": "section 304", "@value": "Federal Food, Drug, and Cosmetic Act/s:304"}], "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(h)"}, "@id": "H709D3A444E9648CFA61D7A09F82B05E6", "#text": "\n          "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "HE149ACBBC28F41AE876E9ACBA3D870E0"}, "#text": "\n      ", "@id": "H22234AC4CD7B4181965D5A142A870B7C"}], "#text": "\n\t\t", "@id": "HD3FA18DE067B4AE085C4234B3DE053E3"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-12-11"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 5874 IH: Tim Fagan\u2019s Law"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}